Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats.

Source:http://linkedlifedata.com/resource/pubmed/id/8068458

Download in:

View as

General Info

PMID
8068458